Cargando…
A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma
INTRODUCTION: Glioblastoma (GBM) is one of the most frequent primary intracranial malignancies, with limited treatment options and poor overall survival rates. Alternated glucose metabolism is a key metabolic feature of tumour cells, including GBM cells. However, due to high cellular heterogeneity,...
Autores principales: | Zhang, Chaocai, Wang, Minjie, Ji, Fenghu, Peng, Yizhong, Wang, Bo, Zhao, Jiannong, Wu, Jiandong, Zhao, Hongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847336/ https://www.ncbi.nlm.nih.gov/pubmed/33553434 http://dx.doi.org/10.1155/2021/8872977 |
Ejemplares similares
-
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
por: Wang, Minjie, et al.
Publicado: (2022) -
Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021) -
CAR-T: a potential gene carrier targeting solid tumor immune microenvironment
por: Wang, Minjie, et al.
Publicado: (2021) -
A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme
por: Zhao, Jingwei, et al.
Publicado: (2019) -
Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients
por: Cheng, Lijing, et al.
Publicado: (2021)